Prognostic and therapeutic value of disruptor of telomeric silencing-1-like (DOT1L) expression in patients with ovarian cancer

Overview of attention for article published in Journal of Hematology & Oncology, January 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

news: 1 news outlet

Citations

dimensions_citation: 40 Dimensions

Readers on

mendeley: 34 Mendeley

Summary News Dimensions citations

So far, Altmetric has seen 1 news story.

Combinatorial targeting of menin and the histone methyltransferase DOT1L as a novel therapeutic strategy for treatment of chemotherapy-resistant ovarian cancer

Cancer Cell International, 04 Nov 2022

Abstract Background Ovarian cancer (OC) is characterized by a low response rate and high frequency of resistance development to…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.